1. Home
  2. Labeler Index
  3. Abbvie Inc.
  4. 0074-2625
  5. NDC Package Code: 0074-2625-01 Mavyret

NDC Package 0074-2625-01 Mavyret

Glecaprevir And Pibrentasvir Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0074-2625-01
Package Description:
1 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
Product Code:
0074-2625
Proprietary Name:
Mavyret
Non-Proprietary Name:
Glecaprevir And Pibrentasvir
Substance Name:
Glecaprevir; Pibrentasvir
Usage Information:
This medication is a combination of glecaprevir and pibrentasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Glecaprevir and pibrentasvir work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis) or liver cancer. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (such as the use of latex condoms) to lower the risk of passing the virus to others.
11-Digit NDC Billing Format:
00074262501
NDC to RxNorm Crosswalk:
  • RxCUI: 1940703 - glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet
  • RxCUI: 1940709 - Mavyret 100 MG / 40 MG Oral Tablet
  • RxCUI: 1940709 - glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]
  • RxCUI: 1940709 - Mavyret (glecaprevir 100 MG / pibrentasvir 40 MG) Oral Tablet
  • RxCUI: 2557906 - glecaprevir 50 MG / pibrentasvir 20 MG per packet Oral Pellet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Abbvie Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • GLECAPREVIR 100 mg/1
  • PIBRENTASVIR 40 mg/1
    • Pharmacologic Class(es):
  • Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
  • Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 1A2 Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
  • HCV NS3/4A Protease Inhibitors - [MoA] (Mechanism of Action)
  • Hepatitis C Virus NS3/4A Protease Inhibitor - [EPC] (Established Pharmacologic Class)
  • Hepatitis C Virus NS5A Inhibitor - [EPC] (Established Pharmacologic Class)
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors - [MoA] (Mechanism of Action)
  • P-Glycoprotein Inhibitors - [MoA] (Mechanism of Action)
  • UGT1A1 Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA209394
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-03-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0074-2625-284 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
    0074-2625-562 CARTON in 1 CARTON / 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
    0074-2625-8484 TABLET, FILM COATED in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0074-2625-01?

    The NDC Packaged Code 0074-2625-01 is assigned to a package of 1 dose pack in 1 carton / 3 tablet, film coated in 1 dose pack of Mavyret, a human prescription drug labeled by Abbvie Inc.. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 0074-2625 included in the NDC Directory?

    Yes, Mavyret with product code 0074-2625 is active and included in the NDC Directory. The product was first marketed by Abbvie Inc. on August 03, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0074-2625-01?

    The 11-digit format is 00074262501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20074-2625-015-4-200074-2625-01